{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:09:31Z","timestamp":1783613371812,"version":"3.55.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM142521, RO1ES027353, RO3AG075465"],"award-info":[{"award-number":["T32GM142521, RO1ES027353, RO3AG075465"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002193","name":"Lupus Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Lipopolysaccharide (LPS)-accelerated autoimmune glomerulonephritis (GN) in NZBWF1 mice is a preclinical model potentially applicable for investigating lipidome-modulating interventions against lupus. LPS can be expressed as one of two chemotypes: smooth LPS (S-LPS) or rough LPS (R-LPS) which is devoid of O-antigen polysaccharide sidechain. Since these chemotypes differentially affect toll-like receptor 4 (TLR4)-mediated immune cell responses, these differences may influence GN induction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We initially compared the effects of subchronic intraperitoneal (i.p.) injection for 5 wk with 1) <jats:italic>Salmonella<\/jats:italic> S-LPS, 2) <jats:italic>Salmonella<\/jats:italic> R-LPS, or 3) saline vehicle (VEH) (Study 1) in female NZBWF1 mice. Based on the efficacy of R-LPS in inducing GN, we next used it to compare the impact of two lipidome-modulating interventions, \u03c9-3 polyunsaturated fatty acid (PUFA) supplementation and soluble epoxide hydrolase (sEH) inhibition, on GN (Study 2). Specifically, effects of consuming \u03c9-3 docosahexaenoic acid (DHA) (10 g\/kg diet) and\/or the sEH inhibitor 1-(4-trifluoro-methoxy-phenyl)-3-(1-propionylpiperidin-4-yl) urea (TPPU) (22.5 mg\/kg diet \u2248 3 mg\/kg\/day) on R-LPS triggering were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In Study 1, R-LPS induced robust elevations in blood urea nitrogen, proteinuria, and hematuria that were not evident in VEH- or S-LPS-treated mice. R-LPS-treated mice further exhibited kidney histopathology including robust hypertrophy, hyperplasia, thickened membranes, lymphocytic accumulation containing B and T cells, and glomerular IgG deposition consistent with GN that was not evident in VEH- or SLPS-treated groups. R-LPS but not S-LPS induced spleen enlargement with lymphoid hyperplasia and inflammatory cell recruitment in the liver. In Study 2, resultant blood fatty acid profiles and epoxy fatty acid concentrations reflected the anticipated DHA- and TPPU-mediated lipidome changes, respectively. The relative rank order of R-LPS-induced GN severity among groups fed experimental diets based on proteinuria, hematuria, histopathologic scoring, and glomerular IgG deposition was: VEH\/CON&amp;lt; R-LPS\/DHA \u2248 R-LPS\/TPPU&amp;lt;&amp;lt;&amp;lt; R-LPS\/TPPU+DHA \u2248 R-LPS\/CON. In contrast, these interventions had modest-to- negligible effects on R-LPS-induced splenomegaly, plasma antibody responses, liver inflammation, and inflammation-associated kidney gene expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>We show for the first time that absence of O-antigenic polysaccharide in R-LPS is critical to accelerated GN in lupus-prone mice. Furthermore, intervention by lipidome modulation through DHA feeding or sEH inhibition suppressed R-LPS-induced GN; however, these ameliorative effects were greatly diminished upon combining the treatments.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1124910","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:37:20Z","timestamp":1676547440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Lipidome modulation by dietary omega-3 polyunsaturated fatty acid supplementation or selective soluble epoxide hydrolase inhibition suppresses rough LPS-accelerated glomerulonephritis in lupus-prone mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Olivia K.","family":"Favor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Harkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Sing Stephen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Pestka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update omicronn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102359","article-title":"The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus","volume":"110","author":"Catalina","year":"2020","journal-title":"J Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.924766","article-title":"The role of organ-deposited igg in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.02.003","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"24","author":"Flores-Mendoza","year":"2018","journal-title":"Trends Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00608","article-title":"Sle: Another autoimmune disorder influenced by microbes and diet","volume":"6","author":"Mu","year":"2015","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150814269","article-title":"Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease","volume":"15","author":"Parks","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100078","article-title":"Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease","volume":"4","author":"Battaglia","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02608","article-title":"Triggers of autoimmunity: The role of bacterial infections in the extracellular exposure of lupus nuclear autoantigens","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/858027","article-title":"The influence and role of microbial factors in autoimmune kidney diseases: A systematic review","volume":"2015","author":"Kronbichler","year":"2015","journal-title":"J Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02676-14","article-title":"Dynamics of gut microbiota in autoimmune lupus","volume":"80","author":"Zhang","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160613084","article-title":"Roles of b cell-intrinsic tlr signals in systemic lupus erythematosus","volume":"16","author":"Ma","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-013-8402-y","article-title":"Tlr2 and Tlr4 in autoimmune diseases: A comprehensive review","volume":"47","author":"Liu","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7243\/2055-2394-1-1","article-title":"Sex differences in monocytes and Tlr4 associated immune responses; implications for systemic lupus erythematosus (Sle)","volume":"1","author":"Jiang","year":"2014","journal-title":"J Immunother Appl"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.07.007","article-title":"Transgenic overexpression of anti-Double-Stranded DNA autoantibody and activation of toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes","volume":"35","author":"Lee","year":"2010","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1983.204","article-title":"Altered glomerular permeability in the early phase of immune complex nephritis","volume":"24","author":"Cavallo","year":"1983","journal-title":"Kidney Int"},{"key":"B17","article-title":"Animal model of human disease. proliferative glomerulonephritis associated with polyclonal b-cell activation","volume":"114","author":"Cavallo","year":"1984","journal-title":"Am J Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05187.x","article-title":"Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice","volume":"79","author":"Cavallo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"B19","article-title":"Induction of circulating immune-complexes and their renal localization after acute or chronic polyclonal b-cell activation in mice","volume":"21","author":"Ramos-Niembro","year":"1982","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05482.x","article-title":"Lipopolysaccharide from gram-negative bacteria enhances polyclonal b cell activation and exacerbates nephritis in Mrl\/Lpr mice","volume":"82","author":"Cavallo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"B21","article-title":"Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune-complexes in Nzb\/W mice","volume":"137","author":"Cavallo","year":"1990","journal-title":"Am J Pathol"},{"key":"B22","article-title":"Accelerated (Proliferative) lupus nephritis","volume":"137","author":"Cavallo","year":"1990","journal-title":"Am J Pathol"},{"key":"B23","article-title":"Acceleration of glomerulonephritis in nzb X nzw mice by early immunization with DNA and injection of bacterial lipopolysaccharide. experimental approach to the treatment of lupus nephritis by use of the accelerated model of nzb X nzw mouse disease","volume":"4","author":"Fournie","year":"1980","journal-title":"J Clin Lab Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05717.x","article-title":"Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in bxsb lupus-prone mice","volume":"85","author":"Granholm","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/096120339200100409","article-title":"Bacterial lipopolysaccharide causes variable deposits of diverse immunoglobulin isotypes in kidneys of lupus-prone mice","volume":"1","author":"Granholm","year":"1992","journal-title":"Lupus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic lupus erythematosus (Sle) therapy: The old and the new","volume":"7","author":"Basta","year":"2020","journal-title":"Rheumatol Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41584-018-0133-2","article-title":"New therapeutic strategies in systemic lupus erythematosus management","volume":"15","author":"Gatto","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.08.008","article-title":"Moving forward with biologics in lupus nephritis","volume":"26","author":"Hobeika","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1756","article-title":"Lipids in parenteral nutrition: Biological aspects","author":"Calder","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/rhu.0000000000000563","article-title":"Omega-3 fatty acids in rheumatic diseases: A critical review","volume":"23","author":"Akbar","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01796","article-title":"Requisite omega-3 hufa biomarker thresholds for preventing murine lupus flaring","volume":"11","author":"Wierenga","year":"2020","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102688","article-title":"Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis","volume":"19","author":"Duarte-Garcia","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211067985","article-title":"The effect of omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review","volume":"31","author":"Ramessar","year":"2022","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/jm100691c","article-title":"1-Aryl-3-(1-Acylpiperidin-4-Yl)Urea inhibitors of human and murine soluble epoxide hydrolase: Structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain","volume":"53","author":"Rose","year":"2010","journal-title":"J Med Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01641.x","article-title":"Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys","volume":"165","author":"Ulu","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1021\/jm500694p","article-title":"Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy","volume":"57","author":"Lee","year":"2014","journal-title":"J Med Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123873","article-title":"Cyp450 epoxygenase metabolites, epoxyeicosatrienoic acids, as novel anti-inflammatory mediators","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.1038\/s41598-019-45299-5","article-title":"Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in Nzb\/W F1 mice","volume":"9","author":"Klocke","year":"2019","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094650","article-title":"A soluble epoxide hydrolase inhibitor, 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-Yl) urea, ameliorates experimental autoimmune encephalomyelitis","volume":"22","author":"Jonnalagadda","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000415R","article-title":"Soluble epoxide hydrolase inhibitor, tppu, increases regulatory T cells pathway in an arthritis model","volume":"34","author":"Trindade-da-Silva","year":"2020","journal-title":"FASEB J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1422590112","article-title":"Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides","volume":"112","author":"Lopez-Vicario","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2011-0359OC","article-title":"Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease","volume":"46","author":"Wang","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1165\/rcmb.2013-0440OC","article-title":"Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice","volume":"52","author":"Yang","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000000767","article-title":"Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice","volume":"47","author":"Zhou","year":"2017","journal-title":"Shock"},{"key":"B46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00441-015-2262-0","article-title":"Soluble epoxide hydrolase inhibitor 1-Trifluoromethoxyphenyl-3- (1-Propionylpiperidin-4-Yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"363","author":"Zhou","year":"2016","journal-title":"Cell Tissue Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102490","article-title":"Are lupus animal models useful for understanding and developing new therapies for human sle","volume":"112","author":"Moore","year":"2020","journal-title":"J Autoimmun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801610","article-title":"Tris dba ameliorates accelerated and severe lupus nephritis in mice by activating regulatory T cells and autophagy and inhibiting the Nlrp3 inflammasome","volume":"204","author":"Wu","year":"2020","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.05.016","article-title":"Epigallocatechin-3-Gallate prevents lupus nephritis development in mice Via enhancing the Nrf2 antioxidant pathway and inhibiting Nlrp3 inflammasome activation","volume":"51","author":"Tsai","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00706.2010","article-title":"Therapeutic potential of dcb-Sle1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis","volume":"301","author":"Tsai","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13075-015-0844-6","article-title":"Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of Nlrp3 inflammasome and enhancing Nrf2 activation","volume":"17","author":"Ka","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01951","article-title":"Accelerated and severe lupus nephritis benefits from M1, an active metabolite of ginsenoside, by regulating Nlrp3 inflammasome and T cell functions in mice","volume":"10","author":"Lin","year":"2019","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001326R","article-title":"Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating nf-Kappab\/Nlrp3 inflammasome and sirtuin 1\/Autophagy axis","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.02.033","article-title":"Xenon blunts nf-Kappab\/Nlrp3 inflammasome activation and improves acute onset of accelerated and severe lupus nephritis in mice","volume":"98","author":"Yang","year":"2020","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/09680519010070030101","article-title":"Bacterial lipopolysaccharides and innate immunity","volume":"7","author":"Alexander","year":"2001","journal-title":"J Endotoxin Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/ct500075h","article-title":"Outer membrane remodeling: The structural dynamics and electrostatics of rough lipopolysaccharide chemotypes","volume":"10","author":"Dias","year":"2014","journal-title":"J Chem Theory Comput"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535593","article-title":"R-form lps, the master key to the activation of Tlr4\/Md-2-Positive cells","volume":"36","author":"Huber","year":"2006","journal-title":"Eur J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12104","article-title":"Intact rough- and smooth-form lipopolysaccharides from escherichia coli separated by preparative gel electrophoresis exhibit differential biologic activity in human macrophages","volume":"280","author":"Pupo","year":"2013","journal-title":"FEBS J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/ni1207","article-title":"Cd14 is required for Myd88-independent lps signaling","volume":"6","author":"Jiang","year":"2005","journal-title":"Nat Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/art.33328","article-title":"Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis","volume":"64","author":"Tsai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2000.7173","article-title":"The pathogenesis of autoimmunity in new Zealand mice","volume":"29","author":"Borchers","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/123.11.1939","article-title":"Ain-93 purified diets for laboratory rodents: Final report of the American institute of nutrition Ad hoc writing committee on the reformulation of the ain-76a rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J Nutr"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160622","article-title":"Silica-triggered autoimmunity in lupus-prone mice blocked by docosahexaenoic acid consumption","volume":"11","author":"Bates","year":"2016","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/foods11213404","article-title":"Fatty acid and antioxidant profile of eggs from pasture-raised hens fed a corn- and soy-free diet and supplemented with grass-fed beef suet and liver","volume":"11","author":"Sergin","year":"2022","journal-title":"Foods"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7592-1_10","article-title":"Lc-Ms\/Ms analysis of the epoxides and diols derived from the endocannabinoid arachidonoyl ethanolamide","volume":"1730","author":"Rand","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: Clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653464","article-title":"Omega-3 polyunsaturated fatty acid intervention against established autoimmunity in a murine model of toxicant-triggered lupus","volume":"12","author":"Pestka","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2022.102397","article-title":"The omega-3 index is inversely associated with the neutrophil-lymphocyte ratio in adults'","volume":"177","author":"McBurney","year":"2022","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12136","article-title":"Lack of rewarding effects of a soluble epoxide hydrolase inhibitor tppu in mice: Comparison with morphine","volume":"40","author":"Wan","year":"2020","journal-title":"Neuropsychopharmacol Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17548","article-title":"Inhibition of soluble epoxide hydrolase attenuates bosutinib-induced blood pressure elevation","volume":"78","author":"Cui","year":"2021","journal-title":"Hypertension"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601532113","article-title":"Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress","volume":"113","author":"Ren","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1039\/C7FO00403F","article-title":"Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: A short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids","volume":"8","author":"Ostermann","year":"2017","journal-title":"Food Funct"},{"key":"B74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/ijms19010180","article-title":"Effect of omega-3 fatty acid supplementation on oxylipins in a routine clinical setting","volume":"19","author":"Schm\u00f6cker","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of \u03a9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in Angiotensin-Ii\u2013dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem136","article-title":"Lps-evoked il-18 expression in mesangial cells plays a role in accelerating lupus nephritis","volume":"46","author":"Shui","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neubiorev.2020.05.001","article-title":"Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression","volume":"115","author":"Lasselin","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02002","article-title":"Dietary docosahexaenoic acid prevents silica-induced development of pulmonary ectopic germinal centers and glomerulonephritis in the lupus-prone Nzbwf1 mouse","volume":"9","author":"Bates","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12986-017-0230-2","article-title":"Retroconversion is a minor contributor to increases in eicosapentaenoic acid following docosahexaenoic acid feeding as determined by compound specific isotope analysis in rat liver","volume":"14","author":"Metherel","year":"2017","journal-title":"Nutr Metab (Lond)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903282","article-title":"Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice","volume":"184","author":"Halade","year":"2010","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213489485","article-title":"Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (Nzbxnzw)F1 mice","volume":"238","author":"Halade","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100255","article-title":"Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and Cd4+ T cell-related gene responses in the autoimmune Nzbwf1 mouse","volume":"9","author":"Pestka","year":"2014","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23925","article-title":"Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: The Michigan lupus epidemiology and surveillance program","volume":"72","author":"Charoenwoodhipong","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02241","article-title":"Therapeutic potential of omega-3 polyunsaturated fatty acids in human autoimmune diseases","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02130","article-title":"Docosahexaenoic acid suppresses silica-induced inflammasome activation and il-1 cytokine release by interfering with priming signal","volume":"10","author":"Wierenga","year":"2019","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.993614","article-title":"Single cell analysis of docosahexaenoic acid suppression of sequential lps-induced proinflammatory and interferon-regulated gene expression in the macrophage","volume":"13","author":"Wierenga","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02179","article-title":"Omega-3 docosahexaenoic acid (Dha) impedes silica-induced macrophage corpse accumulation by attenuating cell death and potentiating efferocytosis","volume":"11","author":"Rajasinghe","year":"2020","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02851","article-title":"Docosahexaenoic acid consumption impedes early interferon- and chemokine-related gene expression while suppressing silica-triggered flaring of murine lupus","volume":"10","author":"Benninghoff","year":"2019","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2020.1801651","article-title":"Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice","volume":"53","author":"Rajasinghe","year":"2020","journal-title":"Autoimmunity"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781446","article-title":"Silica induction of diverse inflammatory proteome in lungs of lupus-prone mice quelled by dietary docosahexaenoic acid supplementation","volume":"12","author":"Rajasinghe","year":"2021","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668760","article-title":"Resolvin D1 improves the Treg\/Th17 imbalance in systemic lupus erythematosus through mir-30e-5p","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: A target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J Med Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.097501","article-title":"Soluble epoxide hydrolase pharmacological inhibition ameliorates experimental acute pancreatitis in mice","volume":"88","author":"Bettaieb","year":"2015","journal-title":"Mol Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.03.022","article-title":"Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice","volume":"286","author":"Harris","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.232108","article-title":"Anti-ulcer efficacy of soluble epoxide hydrolase inhibitor tppu on diclofenac-induced intestinal ulcers","volume":"357","author":"Goswami","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000001151","article-title":"Soluble epoxide hydrolase inhibition and epoxyeicosatrienoic acid treatment improve vascularization of engineered skin substitutes","volume":"4","author":"Supp","year":"2016","journal-title":"Plast reconstructive Surg Global Open"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1038\/s41598-017-08227-z","article-title":"Soluble epoxide hydrolase inhibition promotes white matter integrity and long-term functional recovery after chronic hypoperfusion in mice","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24080","article-title":"The effects of seh inhibitor on depression-like behavior and neurogenesis in Male mice","volume":"95","author":"Wu","year":"2017","journal-title":"J Neurosci Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0726-9","article-title":"Soluble epoxide hydrolase inhibition attenuates mptp-induced neurotoxicity in the nigrostriatal dopaminergic system: Involvement of \u03b1-synuclein aggregation and er stress","volume":"55","author":"Huang","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12559","article-title":"Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption","volume":"53","author":"Napimoga","year":"2018","journal-title":"J Periodontal Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1038\/s41598-018-23504-1","article-title":"Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia","volume":"8","author":"Tu","year":"2018","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00464","article-title":"In vitro and in vivo metabolism of a potent inhibitor of soluble epoxide hydrolase, 1-(1-Propionylpiperidin-4-Yl)-3-(4-(Trifluoromethoxy)Phenyl)Urea","volume":"10","author":"Wan","year":"2019","journal-title":"Front Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jnutbio.2016.08.010","article-title":"An omega-3-Enriched diet alone does not attenuate Ccl4-induced hepatic fibrosis","volume":"38","author":"Harris","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113523","article-title":"Cytochrome P450 metabolism of polyunsaturated fatty acids and neurodegeneration","volume":"12","author":"Sarparast","year":"2020","journal-title":"Nutrients"},{"key":"B108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1165\/rcmb.2007-0232OC","article-title":"Eet displays anti-inflammatory effects in tnf-alpha stimulated human bronchi: Putative role of cpi-17","volume":"38","author":"Morin","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M031914","article-title":"Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to mcp-1 in vitro and in vivo","volume":"54","author":"Kundu","year":"2013","journal-title":"J Lipid Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3221","article-title":"Targeted metabolomics identifies the cytochrome P450 monooxygenase eicosanoid pathway as a novel therapeutic target of colon tumorigenesis","volume":"79","author":"Wang","year":"2019","journal-title":"Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (Dha) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58128","article-title":"Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice","volume":"122","author":"Panigrahy","year":"2012","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521453113","article-title":"Cyp450-derived oxylipins mediate inflammatory resolution","volume":"113","author":"Gilroy","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-010-0804-6","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pflugers Arch"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.84.4.484","article-title":"Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone","volume":"84","author":"Campbell","year":"1999","journal-title":"Circ Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","article-title":"20-hete: Hypertension and beyond","volume":"72","author":"Roman","year":"2018","journal-title":"Hypertension"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-hete and blood pressure regulation: Clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiol Rev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biochi.2019.01.020","article-title":"Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation","volume":"159","author":"Kodani","year":"2019","journal-title":"Biochimie"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001408","article-title":"Seh inhibitor tppu ameliorates cecal ligation and puncture-induced sepsis by regulating macrophage functions","volume":"53","author":"Chen","year":"2020","journal-title":"Shock"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705615114","article-title":"Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in Gsk3beta signaling","volume":"114","author":"Deng","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311565110","article-title":"Epoxyeicosanoids promote organ and tissue regeneration","volume":"110","author":"Panigrahy","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2003.08.060","article-title":"11,12-epoxyeicosatrienoic acid (11,12-eet): Structural determinants for inhibition of tnf-Alpha-Induced vcam-1 expression","volume":"13","author":"Falck","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2015.06.005","article-title":"Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-Propanoylpiperidin-4-Yl)-3-[4-(Trifluoromethoxy)Phenyl]Urea (Tppu): Resulting drug levels and modulation of oxylipin pattern","volume":"121","author":"Ostermann","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1124910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T11:37:27Z","timestamp":1676547447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1124910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2023.1124910"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1124910","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1124910"}}